• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症认知进展与复发无关。

Cognitive progression independent of relapse in multiple sclerosis.

机构信息

MS Center Amsterdam, Department of Anatomy and Neurosciences, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.

Jacobs Multiple Sclerosis Center for Treatment and Research, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

出版信息

Mult Scler. 2024 Oct;30(11-12):1468-1478. doi: 10.1177/13524585241256540. Epub 2024 Aug 28.

DOI:10.1177/13524585241256540
PMID:39193699
Abstract

BACKGROUND

Substantial physical-disability worsening in relapsing-remitting multiple sclerosis (RRMS) occurs outside of clinically recorded relapse. This phenomenon, termed progression independent of relapse activity (PIRA), is yet to be established for cognitive decline.

METHODS

Retrospective analysis of RRMS patients. Cognitive decline was defined using reliable-change-index cut-offs for each test (Symbol Digit Modalities Test, Brief Visuospatial Memory Test-Revised, California Verbal Learning Test-II). Decline was classified as PIRA if the following conditions were met: no relapse observed between assessments nor within 9 months of cognitive decline.

RESULTS

The study sample ( = 336) was 80.7% female with a mean (standard deviation (SD)) age, disease duration, and observation period of 43.1 (9.5), 10.8 (8.4), and 8.1 (3.1) years, respectively. A total of 169 (50.3%) subjects were cognitively impaired at baseline relative to age-, sex-, and education-matched HCs. Within subjects who experienced cognitive decline ( = 167), 89% experienced cognitive PIRA. A total of 141 (68.1%) cognitive decline events were observed independent of EDSS worsening. Cognitive PIRA was more likely to be observed with increased assessments ( < 0.001) and lower assessment density ( < 0.001), accounting for baseline clinical factors.

CONCLUSION

These results establish the concept of cognitive PIRA and further our understanding of progressive cognitive decline in RRMS.

摘要

背景

在复发缓解型多发性硬化症(RRMS)中,大量的身体残疾恶化发生在临床记录的复发之外。这种现象称为与复发活动无关的进展(PIRA),但尚未在认知能力下降中得到证实。

方法

对 RRMS 患者进行回顾性分析。认知能力下降是使用每个测试的可靠变化指数(SDMT、BVMT-R、CVLT-II)的截定点来定义的。如果满足以下条件,则将下降归类为 PIRA:在评估之间或认知下降后 9 个月内未观察到复发。

结果

研究样本(n=336)中 80.7%为女性,平均(标准差)年龄、疾病持续时间和观察期分别为 43.1(9.5)、10.8(8.4)和 8.1(3.1)年。与年龄、性别和教育匹配的 HC 相比,基线时共有 169 名(50.3%)受试者存在认知障碍。在经历认知能力下降的受试者中(n=167),89%经历了认知 PIRA。共有 141 次(68.1%)认知下降事件与 EDSS 恶化无关。认知 PIRA 更可能随着评估次数的增加(<0.001)和评估密度的降低(<0.001)而观察到,这与基线临床因素有关。

结论

这些结果确立了认知 PIRA 的概念,并进一步加深了我们对 RRMS 中进行性认知能力下降的理解。

相似文献

1
Cognitive progression independent of relapse in multiple sclerosis.多发性硬化症认知进展与复发无关。
Mult Scler. 2024 Oct;30(11-12):1468-1478. doi: 10.1177/13524585241256540. Epub 2024 Aug 28.
2
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.在两项随机临床试验的汇总分析中,复发无关进展与复发相关恶化对典型复发型多发性硬化症总体确认残疾累积的贡献。
JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.
3
Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.简要国际认知评估多发性硬化症(BICAMS):丹麦在多发性硬化症早期阶段的敏感性验证研究。
Mult Scler Relat Disord. 2020 Jan;37:101458. doi: 10.1016/j.msard.2019.101458. Epub 2019 Oct 18.
4
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.血清神经胶质纤维酸性蛋白与多发性硬化症复发活动无关的进展相关联。
J Neurol. 2024 Jul;271(7):4412-4422. doi: 10.1007/s00415-024-12389-y. Epub 2024 Apr 26.
5
Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.多发性硬化症认知能力下降的预测:一项 5 年随访研究。
Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.
6
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.复发缓解型多发性硬化疾病进展与复发活动无关:影响及其与继发进展的关系。
J Neurol. 2024 Aug;271(8):5074-5082. doi: 10.1007/s00415-024-12448-4. Epub 2024 May 28.
7
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis.嗅觉阈值作为多发性硬化症长期复发活动的生物标志物。
Mult Scler Relat Disord. 2024 May;85:105545. doi: 10.1016/j.msard.2024.105545. Epub 2024 Mar 11.
8
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials.奥瑞珠单抗治疗复发型多发性硬化队列的真实世界证据显示,疾病进展的变化与 3 期临床试验一致,与复发活动无关。
Sci Rep. 2023 Sep 11;13(1):15003. doi: 10.1038/s41598-023-40940-w.
9
Inclusion of the Symbol Digit Modalities Test in a revised assessment of 'no evidence of disease activity-4 (NEDA-4)' in Latin-American patients with multiple sclerosis.将符号数字模态测验纳入拉丁美洲多发性硬化症患者修订后的“无疾病活动-4 (NEDA-4)”评估中。
Mult Scler Relat Disord. 2020 Jul;42:102076. doi: 10.1016/j.msard.2020.102076. Epub 2020 Apr 26.
10
How patients with multiple sclerosis acquire disability.多发性硬化症患者如何致残。
Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016.

引用本文的文献

1
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.复发缓解型多发性硬化早期的威胁性疾病认知及相关因素
Front Psychiatry. 2025 Jul 8;16:1565150. doi: 10.3389/fpsyt.2025.1565150. eCollection 2025.
2
Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.用于解释疾病严重程度的脑容量多发性硬化症特异性参考曲线。
Neurology. 2025 May 27;104(10):e213618. doi: 10.1212/WNL.0000000000213618. Epub 2025 Apr 23.
3
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.
神经科医生对血清神经丝轻链检测在伴认知障碍的复发缓解型多发性硬化管理中的态度
J Pers Med. 2025 Feb 14;15(2):69. doi: 10.3390/jpm15020069.